Lymphatic endothelial cell junctional pathway

The lymphatic endothelial cell junctional pathway refers to the specialized protein complexes, including adherens and tight junctions, that regulate the permeability and structural integrity of the lymphatic vasculature (Source: Baluk et al., 2007, Journal of Experimental Medicine). In initial lymphatic capillaries, these junctions are organized into discontinuous button-like structures that facilitate the entry of interstitial fluid, macromolecules, and immune cells (Source: Zhang et al., 2020, Frontiers in Physiology). Conversely, collecting lymphatic vessels feature continuous zipper-like junctions that prevent leakage during lymph transport (Source: Dejana et al., 2009, Nature Reviews Molecular Cell Biology). Key molecular components such as Vascular Endothelial Cadherin (VE-cadherin), Claudin-5, and Junctional Adhesion Molecules (JAMs) are dynamically regulated by growth factors like VEGF-C and angiopoietins (Source: Zheng et al., 2014, Journal of Clinical Investigation). Dysregulation of this pathway is a critical factor in the development of lymphedema and the facilitation of cancer metastasis, as tumor cells often exploit weakened junctions to enter the lymphatic system (Source: Saharinen et al., 2011, Trends in Molecular Medicine). Therapeutic interventions targeting this pathway, such as VEGFR3 inhibitors or VEGF-C analogs, aim to restore fluid balance or inhibit the spread of malignant cells (Source: Alitalo, 2011, Nature). This pathway is also essential for the transport of dietary lipids from the gut via lacteals, where junctional integrity determines absorption efficiency (Source: Bernier-Latmani et al., 2015, Journal of Clinical Investigation). Overall, the pathway serves as a gatekeeper for fluid homeostasis and immune surveillance, making it a significant focus for vascular biology and oncology research.

Other names

Lymphatic endothelial junctionsLymphatic intercellular junctionsLymphatic button and zipper junctionsLymphatic barrier function

Modulation of the structural integrity and permeability of lymphatic endothelial barriers through the regulation of adherens and tight junction proteins, primarily via the VEGF-C/VEGFR3 and Angiopoietin/Tie2 signaling axes (Source: Saharinen et al., 2011, Trends in Molecular Medicine).